This funding opportunity supports integrative, interdisciplinary research focused on the identification and preclinical validation of novel therapeutic targets within molecular networks involved in different stages of Alzheimers disease (AD) pathogenesis. The use of the multiple Program Director/Principal Investigator (PD/PI) option aims to maximize the potential of team science efforts necessary to achieve the programmatic goals of this funding opportunity.